Ahmed Bahi on Qatar’s Self-Infusion Program for Hemophilia Patients
Ahmed Bahi, Critical Care Pharmacist Specialist in Trauma Services at Hamad Medical Corporation, shared on LinkedIn:
”Exciting News from Qatar!
I’m thrilled to share the successful establishment of our self-infusion program for hemophilia patients, a collaborative effort between Qatar Foundation Health Group (QFHG) and the Hematology/Oncology team at Hamad Medical Corporation’s National Center for Cancer Care and Research (NCCCR).
This initiative included comprehensive didactic lectures and hands-on live stations, culminating in a knowledge assessment survey to ensure our patients feel empowered and informed.
A heartfelt thank you to everyone involved, especially:
– Dr. Osama Elhomsi
– Dr. Honar Cherif
– Dr. Liam Ferrnough
– Dr.Sheab Fared
– Dr.Amna Jameel
– Dr.Deena Mudawi
Your dedication and expertise made this program a reality, significantly improving the quality of life for hemophilia patients in our community.
Together, we are making strides toward better healthcare and patient empowerment!”
Stay updated with Hemostasis Today.
-
Jan 12, 2026, 01:55Frank Weinz on State-of-the-Art Thromboembolism Prophylaxis
-
Jan 12, 2026, 01:45Khurram Nasir on Where The Cholesterol Guidelines Are Headed
-
Jan 12, 2026, 01:35Nirav Dhanesha Shares The Lab’s Latest Publication on Neutrophil CD14 and DVT Link
-
Jan 12, 2026, 01:07Akshat Jain Presents The New Edition of Global Sickle Cell Disease Insight Publication
-
Jan 11, 2026, 21:05Simona Sacco Shares Expert Guidance for Clinicians on Minor Ischemic Stroke
-
Jan 11, 2026, 11:00Benjamin YQ Tan on Impacts of Early Cognitive and Psychological Statuses Post-Stroke
-
Jan 11, 2026, 10:46Salvador Payán Pernía: Leukodepletion Reduces Microplastic Burden in Red Blood Cell Concentrates
-
Jan 11, 2026, 10:36Mariasanta Napolitano on Pregnancy and Delivery Outcomes in Women with Hemophilia
-
Jan 11, 2026, 10:19Quick Explanation of Types of Blood Transfusion from John Amako